One-year Prevalence, Comorbidities, and Cost of Hospitalizations for Alpha-1 Antitrypsin Deficiency among Patients with Chronic Obstructive Pulmonary Disease in the United States
# Objectives Little is known about severe chronic obstructive pulmonary disease (COPD) exacerbations among patients with Alpha-1 Antitrypsin Deficiency (AATD). We assessed inpatients with AATD and COPD among a sample of COPD inpatients to ascertain demographic, clinical and economic differences in t...
Saved in:
Main Authors: | Christopher M. Blanchette, Emily Zacherle, Joshua M. Noone, Bryce A. Van Doren, Debosree Roy, Reuben Howden |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2017-07-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/9799 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alpha One Antitrypsin Deficiency: A Pulmonary Genetic Disorder
by: Sjoding, Michael, et al.
Published: (2011) -
Alpha-1-Antitrypsin Deficiency in Children: Case Series
by: Svetlana I. Melnik, et al.
Published: (2016-12-01) -
Gene Therapy for Alpha-1-Antitrypsin Deficiency Diseases
by: Salahuddin, Parveen
Published: (2011) -
Alpha-1 Antitrypsin Deficiency and Bronchial Asthma: Current Challenges
by: José Luis Lopez-Campos, et al.
Published: (2025-06-01) -
Alpha-1 Antitrypsin Deficiency – A Genetic Risk Factor for COPD
by: Carroll, Tomás P., et al.
Published: (2012)